Osaka, Japan

Hajime Seki

This inventor holds 2 USPTO granted patents. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hajime Seki. Retrieved from https://idiyas.com/inventor/hajime-seki-jvmd5h36

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hajime Seki: Innovator in Pharmaceutical Chemistry

Introduction

Hajime Seki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on aminoquinazolinone derivatives. With a total of 2 patents to his name, Seki continues to push the boundaries of medicinal chemistry.

Latest Patents

Hajime Seki's latest patents include a 2-heteroaryl aminoquinazolinone derivative. This compound is represented by a specific formula and is characterized by various substituents that enhance its pharmaceutical properties. The compound is designed to provide potential therapeutic benefits, showcasing Seki's commitment to advancing medical science.

Career Highlights

Seki is currently employed at Sumitomo Pharma Co., Ltd., where he applies his expertise in drug development. His work focuses on creating innovative compounds that can lead to new treatments for various medical conditions. His contributions have been instrumental in the company's research initiatives.

Collaborations

Throughout his career, Hajime Seki has collaborated with esteemed colleagues such as Kazuto Mori and Hiroyuki Kitano. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Hajime Seki is a prominent figure in the field of pharmaceutical innovation. His work on aminoquinazolinone derivatives exemplifies his dedication to improving healthcare through scientific advancements. His contributions continue to inspire future innovations in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…